USP28 and neoplasm: Analysis of publicly available data regarding putative drug sensitivity of tumour cells in direct correlation to USP28 expression scored the PIK3, EGFR and MAPK pathway as top hits (Fig. 7C), which directly confirmed our experimental data regarding USP28 expression relative to oncogenic drivers.